(R)-(6,6'-Dimethoxy-[1,1'-biphenyl]-2,2'-diyl)bis(diphenylphosphine), 97%, 5g

3-(4-tert-Butyl-phenyl)-2-methyl-propan-1-ol, 95.0%, 100mg

L-xilosa, mínimo 99 %, para bioquímica, 5 g, envase de vidrio

2-(Aminomethyl)-6-bromophenol hydrochloride, 95+%, 250mg

(6-(Dimethylamino)-4-methylpyridin-3-yl)boronic acid, 98+%, 100mg

DMH-1>98.0%(HPLC)10mg

Báscula analítica y de precisión serie Entris® II Modelos con ajuste externo, no certificados, 0,0001 g, 120 g, BCE124-1S (W)

2-Ethylimidazole, 97.0%, 25g

N-Acetyl-DL-leucine>98.0%(T)(HPLC)25g

1-Methyl-3-piperidinemethanol, 95.0%, 500g

6-chloro-3-(3-methoxyphenyl)[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg

(3,3,3-Trifluoroprop-1-en-2-yl)boronic acid, 95.0%, 1g

(2-Amino-5-methylphenyl)phosphonic acid, 97.0%, 1g